the short answer
TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in cell migration and tissue repair. The evidence in dogs is preclinical, not controlled clinical trials, and it is not FDA-approved for canine use.
What it is
TB-500 is a fragment of thymosin beta-4. In preclinical models it has been studied for cell migration, flexibility, and repair after strain.
What the research shows
The animal literature is early. Reviews describe tissue-repair and anti-inflammatory activity in models, but not the controlled canine trials that would establish a dose or a benefit.
What it does not show
No canine efficacy trial, no long-term safety data, no FDA approval. The same caution as BPC-157 applies.
Why it is paired with BPC-157
The two are often studied together because they act on different parts of the repair process. That pairing is a hypothesis, not a proven synergy.
Questions owners ask
Is TB-500 FDA-approved for dogs?
No. It is a research compound, not an FDA-approved veterinary drug.
Is TB-500 safe?
Preclinical data is limited. Ask your vet, especially for dogs with cancer, pregnancy, or medication use.
Does it build muscle?
No. It is studied for tissue repair and cell migration, not muscle growth.